Expiratory Muscle Training in Patients With Parkinson's Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-01-31

Study Completion Date

2008-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Respiratory difficulty is one of the primary factors leading to death in patients with Idiopathic Parkinson's Disease (IPD). The progressive degeneration of a family of segregated motor and non-motor circuits in the brain results in motor and non-motor dysfunction. Breathing and swallowing are well known to be affected in IPD, and attention to these functions is fitting since most patients eventually experience morbidity and even mortality as a result of this dysfunction. Patients with IPD typically become sedentary and lose endurance, maximal fitness levels and overall pulmonary function. Much of the research focus has been on the motor symptoms of IPD (tremor, rigidity, bradykinesia) yet the pulmonary complications are perhaps ultimately the most important disability. The inability to generate adequate respiratory pressure is responsible for reduced cough magnitudes and cough response times. Cough is critical for the clearance of foreign materials in the airway helping to reduce infiltration of bacteria and subsequent respiratory infection. With reduced cough function an increased risk for pulmonary disease due to a reduced ability to protect the airways occurs. Moreover, the recognized debilitating disruptions to voice and speech characteristics that limit communication, care taking, employment opportunities and social interactions are also a result of poor respiratory function. There are a number of promising outcomes from an expiratory strength-training program. By increasing expiratory muscle strength and expiratory pressure generation, effective breathing, clearance of the airway, production of a louder and clearer voice as well as improved swallowing can occur. These explicit outcomes are predicted based on our experience with the use of an innovative device-driven, home-based expiratory strength training program focused on the expiratory muscles of respiration.

The aims of this study are to: 1) Investigate the activity of expiratory muscle strength training (EMT) in patients with idiopathic Parkinson's disease (IPD), 2) Determine the effect of increased expiratory force generation on breathing, cough magnitude, speech production, and swallowing, 3) Determine the effect of increased expiratory force generation on the patient's perception of speech change, 4) Determine the effect of Dopamine-replacement therapy (Parkinson's medications) on breathing, coughing, speaking, and swallowing measures.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Expiratory Muscle Training in Parkinson's Disease With Forward Trunk Flexion

NCT07268703

Parkinson's Disease

NOT_YET_RECRUITING NA

Resistance Training in Patients With Parkinson's Disease.

NCT02447146

Parkinson Disease

COMPLETED NA

Effects of Inspiratory Muscle Training on Parkinson's Disease

NCT06912997

Parkinson Disease

ACTIVE_NOT_RECRUITING NA

Masked Faces in Parkinson Disease: Mechanism and Treatment

NCT00350402

Parkinson's Disease

COMPLETED PHASE2

Diaphragmatic Exercise on Parkinson Disease

NCT04108520

Parkinson Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson's Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

EMST

Four week device driven strength training program

Group Type EXPERIMENTAL

EMST - Active Treatment

Intervention Type DEVICE

Hand held device used for strengthening expiratory muscles

sham

Four week sham device driven training program

Group Type SHAM_COMPARATOR

sham EMST

Intervention Type DEVICE

Four week sham device training program

Control

Four weeks of no intervention

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EMST - Active Treatment

Hand held device used for strengthening expiratory muscles

Intervention Type DEVICE

sham EMST

Four week sham device training program

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Respiratory Muscle Strength Training

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults between the age of 35 and 85 years.
* Diagnosis of Idiopathic Parkinson's Disease (either tremor-predominant or rigid- predominant) by their neurologist.
* Disability level of II, III, or IV (Hoehn \& Yahr, 1976) as indicated in their most recent neurological evaluation.
* Forced Expiratory Volumes (FEV1) and forced vital capacity (FVC) within normative range for age and sex determined by a pulmonary function screening.
* Persons who are able to maintain their current level of physical activity (including both aerobic exercise and weightlifting) throughout the entire training period.

\*Subjects will be asked to report any significant changes in their level of activity throughout their participation in the study in regards to intensity and frequency of exercise (i.e. a sedentary person begins exercising three to four days per week).
* Completion of the informed consent to participate in the study.

Exclusion Criteria

* Other neurological disorders
* Positive history of any of the following conditions:

* Gastrointestinal disease
* Gastro-esophageal surgery
* Head or neck cancer
* History of breathing disorders or diseases (e.g., Asthma, chronic obstructive pulmonary disease (COPD)).
* Untreated hypertension
* Heart disease
* History of smoking in the last five years
* Failing the screening test of pulmonary functions (e.g., FEV1/FVC \< 75%)
* Difficulty in complying with the training protocol due to neuropsychological dysfunction (e.g., severe depression).
* Other illness that would prevent patient from completing the protocol.

Minimum Eligible Age

35 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No